Mother-To-newborn transmission of mycobacterial L-forms and Vδ2 T-cell response in placentobiome of BCG-vaccinated pregnant women

Scientific Reports

Volumn 7, Issue 1, 2017, Pages

  Dimova, T ^a   Terzieva, A ^a   Djerov, L ^b   Dimitrova, V ^b   Nikolov, A ^b   Grozdanov, P ^c   Markova, N ^c  

^a BULGARIAN ACADEMY OF SCIENCES   (Bulgaria)

^b University Hospital of Obstetrics and Gynecology 'Maichin Dom' Bulgaria   (Bulgaria)

^c INSTITUTE OF MICROBIOLOGY   (Bulgaria)

Author keywords

[No Author keywords available]

Indexed keywords

BCG VACCINE;

CYTOLOGY; FEMALE; HUMAN; IMMUNOLOGY; INTRAEPITHELIAL LYMPHOCYTE; ISOLATION AND PURIFICATION; MICROBIOLOGY; MICROFLORA; MOTHER; MYCOBACTERIUM BOVIS; NEWBORN; PLACENTA; PREGNANCY; PROTOPLAST; SYMBIOSIS; T LYMPHOCYTE; TUBERCULOSIS; VACCINATION; VERTICAL TRANSMISSION;

BCG VACCINE; FEMALE; HUMANS; INFANT, NEWBORN; INFECTIOUS DISEASE TRANSMISSION, VERTICAL; INTRAEPITHELIAL LYMPHOCYTES; L FORMS; MICROBIOTA; MOTHERS; MYCOBACTERIUM BOVIS; PLACENTA; PREGNANCY; SYMBIOSIS; T-LYMPHOCYTES; TUBERCULOSIS; VACCINATION;

EID: 85037736247     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/s41598-017-17644-z     Document Type: Article

References (77)

1. Stout, M. et al. Identification of intracellular bacteria in the basal plate of the human placenta in term and preterm gestations. Am J Obstet Gynecol. 208, 226.e221-226.e227 (2013).
2. Aagaard, K. et al. The placenta harbors a unique microbiome. Sci Transl Med 21 (2014).
3. Guliang, H. & Tefu, L. Bacterial L-forms research in China. Chinese Medical Journal 109, 18-20 (1996).
4. Markova, N., Michailova, L., Kussovski, V. & Jourdanova, M. Formation of persisting cell wall deficient forms of Mycobacterium bovis BCG during interaction with peritoneal macrophages in guinea pigs. Electronic J Biol 4, 1-10 (2008).
5. Schnell, B. et al. Cell-wall deficient L. monocytogenes L-forms feature abrogated pathogenicity. Front. Cell. Infect. Microbiol. 4, 1-11 (2014).
6. Onwuamaegbu, M., Belcher, R. & Soare, C. Cell wall-deficient bacteria as a cause of infections: A review of the clinical significance. J. Int. Med Res 33, 1-20 (2005).
7. Domingue, G. Demystifying pleomorphic forms in persistence and expression of disease: Are they bacteria, and is peptidoglycan the solution? Discov. Med. 10, 234-246 (2010).
8. Errington, J., Mickiewicz, K., Kawai, Y. & Wu, L. L-form bacteria, chronic diseases and the origins of life. Phil. Trans. R. Soc. B 371, 20150494 (2016).
9. Devadoss, P., Klegerman, M. & Groves, M. A scanning electron microscopy study of mycobacterial development stages in commercial BCG vaccines. Curr Microbiol 22 (1991).
10. Markova, N., Slavchev, G. & Michailova, L. Presence of mycobacterial L-forms in human blood: Challenge of BCG vaccination. Hum Vaccin Immunother 11, 1192-1200 (2015).
11. Markova, N., Slavchev, G., Djerov, L., Nikolov, A. & Dimova, T. Mycobacterial L-forms are found in cord blood: A potential vertical transmission of BCG from vaccinated mothers. Human Vaccines & Immunotherapeutics (2016).
12. Fine, P., Cameiro, I., Milstein, J. & Clements, C. Issues relating to the use of BCG in immunization programmes. A discussion document, World Health Organization, Geneva (1999).
13. Fine, P. Variation in protection by BCG: implications of and for heterologous immunity. Lancet 346, 1339-1345 (1995).
14. Golditz, G. A. et al. Efficacy of BCG vaccine in the prevention of tuberculosis. Meta-Analysis of the published literature. JAMA 271, 698-702 (1994).
15. World Health Organization, (WHO, Geneva, Switzerland, http://www.who.int/vaccinesafety/committee/topics/bcg/en/ 2014).
16. Talbot, E., Perkins, M., Suva, S. & Frothingham, R. Disseminated bacille Calmette-Guerin disease after vaccination:case report and review. Clinical Infectious Diseases 24, 1139-1146 (1997).
17. WHO-UNICEF, http://apps.who.int/immunization-monitoring/globalsummary/timeseries/tswucoveragebcg.html last up-date 15-July-2017., 2017).
18. Hoft, D., Brown, R. & Roodman, S. Bacille Calmette-Guérin vaccination enhances human gamma delta T cell responsiveness to mycobacteria suggestive of a memory-like phenotype. J Immunol 161, 1045-1054 (1998).
19. Constant, P. et al. The antituberculous Mycobacterium bovis BCG vaccine is an attenuated mycobacterial producer of phosphorylated nonpeptidic antigens for human gamma delta T cells. Infect Immun 63, 4628-4633 (1995).
20. Mazzola, T. et al. Robust gammadelta+ T cell expansion in infants immunized at birth with BCG vaccine. Vaccine 25, 6313-6320 (2007).
21. Dimova, T. et al. presented at the γδ T-cell Conference, Kiel, Germany (unpublished) (2010).
22. Havlir, D., Eliner, J., Chervenak, K. & Boom, W. H. Selective Expansion of Human gamma delta T Cells by Monocytes Infected with Live Mycobacterium Tuberculosis. J. Clin. Invest. 87, 729-733 (1991).
23. Dieli, F. et al. Granulysin-Dependent Killing of Intracellular and Extracellular Mycobacterium tuberculosis by Vg9/Vd2 T Lymphocytes. The Journal of Infectious Diseases 184, 1082-1085 (2001).
24. Wang, L., Kamath, A., Das, H., Li, L. & Bukowski, J. F. Antibacterial effect of human V gamma 2V delta 2 T cells in vivo. J. Clin. Invest. 108, 1349-1357 (2001).
25. Shen, Y. et al. Adaptive immune response of Vgamma2Vdelta2+ T cells during mycobacterial infections. Science (Wash. DC) 295, 2255-2258 (2002).
26. Eberl, M. et al. Microbial isoprenoid biosynthesis and human gammadelta T cell activation. FEBS Lett 544 (2003).
27. Kistowska, M. et al. Dysregulation of the host mevalonate pathway during early bacterial infection activates human TCR gamma delta cells. Eur. J. Immunol 38, 2200-2209 (2008).
28. Hayday, A. C. [gamma][delta] cells: A right time and a right place for a conserved third way of protection. Annu. Rev. Immunol 18 (2000).
29. Brandes, M. et al. Flexible migration program regulates gamma delta T-cell involvement in humoral immunity. BLOOD 102, 3693-3701 (2003).
30. Leslie, D. et al. CD1-mediated gamma delta T Cell Maturation of Dendritic Cells. J. Exp. Med. 196, 1575-1584 (2002).
31. Dimova, T. et al. Effector Vγ9Vδ2 T cells dominate the human fetal γδ T-cell repertoire. PNAS 112, E556-E565 (2015).
32. Mincheva-Nilsson, L. et al. γδT cells of human early pregnancy decidua: evidence for local proliferation, phenotypic heterogeneity, and extrathymic differentiation. J Immunol 159, 3266-3277 (1997).
33. Mattman, L. Cell wall Deficient Forms. (CRC Press Inc, Boca Raton, FL USA, 2001).
34. Markova, N. et al. Exhibition of persistent and drug-Tolerant L-form habit of Mycobacterium tuberculosis during infection in rats. Cent Eur J Biol 3, 407-416 (2008).
35. Mathema, B., Kurepina, N., Bifani, P. & Kreiswirth, B. Molecular Epidemiology of Tuberculosis: Current Insights. Clin Microbiol Rev 19, 658-685 (2006).
36. Eberl, M. & Moser, B. Monocytes and gammadelta T cells: close encounters in microbial infection. Trends Immunol 30, 562-568 (2009).
37. Zwerling, A. et al. The BCG World Atlas: A database of global BCG vaccination policies and practices. PLoS Med 8, e1001012 (2011).
38. Briassoulis, G., Karabatsou, I., Gogoglou, V. & Tsorva, A. BCG vaccination at three different age groups: response and effectiveness. J Immune Based Ther Vaccines 3 (2005).
39. Prozorovski, S., Kaz, L. & Kagan, G. Bacterial L-forms: Mechanisms of Formation, Structure, Role inPathology. Moscow: Medicine Publishing (1981).
40. Studer, P. et al. Proliferation of Listeria monocytogenes L-form cells by formation of internal and external vesicles. Nature Communications 7 (2016).
41. Dell'Era, S. et al. Listeria monocytogenes L-forms respond to cell wall deficiency by modifying gene expression and the mode of division. Molecular Microbiology 73, 306-322 (2009).
42. Mercier, R., Kawai, Y. & Errington, J. Excess membrane synthesis drives a primitive mode of cell proliferation. Cell 152, 997-1007 (2013).
43. Domingue, G. Cell-wall Deficient Bacteria: Basic Principles and Clinical Significance. (Reading MA: Addison Wesley Publishing Co, 1982).
44. Allan, E., Hoischen, C. & Gumpert, J. Chapter 1, Bacterial L-Forms. (eds Advances in Applied Microbiology, New York: Academic Press, 2009).
45. Klieneberger-Nobel, E. Filterable forms of bacteria. Bacteriol Rev 15, 77-103 (1951).
46. Brem, A. & Eveland, W. Inducing L Forms in Listeria monocytogenes Types 1 Through 7. Appl Microbiol 15 (1967).
47. Edman, D., Pollock, M. & Hall, E. Listeria monocytogenes L Forms I. Induction, Maintenance, and Biological Characteristics'. J Bacteriol 96, 352-357 (1968).
48. Meeske, A. et al. MurJ and a novel lipid II flippase are required for cell wall biogenesis in Bacillus subtilis. Proc. Natl Acad. Sci. USA 112, 6437-6442 (2015).
49. Mercier, R., Kawai, Y. & Errington, J. General principles for the formation and proliferation of a wall-free (L-form) state in bacteria. eLife 3, e04629 (2014).
50. Kawai, Y., Mercier, R. & Errington, J. Bacterial cell morphogenesis does not require a preexisting template structure. Current Biology 24, 863-867 (2014).
51. Armbruster, C., Junker, W., Vetter, N. & Jaksch, G. Disseminated bacille Calmette-Guérin infection in an AIDS patient 30 years after BCG vaccination. J Infect Dis 162 (1990).
52. Deutekom, H. V., Smulders, Y., Roozendaal, K. & Soolingen, D. V. Bacille Calmette-Guérin (BCG) meningitis in an AIDS patient 12 years after vaccination with BCG. Clin Infect Dis 22, 870-871 (1996).
53. Rosenfeldt, V., Paerregaard, A. & NH, N. V. Disseminated infection with Bacillus Calmette-Guerin in a child with advanced HIV disease. Scand J Infect Dis 29, 526-527 (1997).
54. Capellini, I., Nunn, C. & Barton, R. Microparasites and Placental Invasiveness in Eutherian Mammals. PLoS ONE 10, e0132563 (2015).
55. Robbins, J. & Bakardjiev, A. Pathogens and the placental fortress. Curr Opin Microbiol 15, 36-43 (2012).
56. Dubey, J. et al. Epidemiology of toxoplasmosis in white tailed deer (Odocoileus virginianus): occurrence, congenital transmission, correlates of infection, isolation, and genetic characterization of Toxoplasma gondii. Vet Parasitol. 202, 270-275 (2014).
57. Benirschke, K., Burton, G. & Baergen, R. Pathology of the human placenta. (Springer, 2012).
58. Loke, Y. Transmission of parasites across the placenta. Adv Parasit 21, 155-228 (1982).
59. Webster, P. & Kapel, C. Studies on vertical transmission of Trichinella spp. in experimentally infected ferrets (Mustela putorius furo), foxes (Vulpes vulpes), pigs, guinea pigs and mice. Vet Parasitol. 130, 255-262 (2005).
60. Yamashita, K. et al. Silica and titanium dioxide nanoparticles cause pregnancy complications in mice. Nat Nanotechnol 6, 321-328 (2011).
61. Mincheva-Nilsson, L. & Baranov, V. The role of placental exosomes in reproduction. Am J Reprod Immunol 63, 520-533 (2010).
62. Giri, P. & Schorey, J. Exosomes derived from M. Bovis BCG infected macrophages activate antigen-specific CD4 and CD8 T Cells in vitro and in vivo. PLoS ONE 3, e2461 (2008).
63. Hurtado, C. et al. Innate immune function in placenta and cord blood of hepatitis C-seropositive mother-infant dyads. PLoS One 30 (2010).
64. Constant, P. et al. Stimulation of human gd T cells by nonpeptidic mycobacterial ligands. Science (Wash. DC) 264, 267-270 (1994).
65. Andersen, P. & Kaufmann, S. Novel Vaccination Strategies against Tuberculosis. Cold Spring Harb Perspect Med 4, a018523 (2014).
66. Mogensen, T. Pathogen recognition and inflammatory signaling in innate immune defenses. Clin Microbiol Rev 22, 240-273 (2009).
67. Akira, S., Uematsu, S. & Takeuchi, O. Pathogen recognition and innate immunity. Cell 124, 783-801 (2006).
68. Sukhithasri, V., N, N. N., Biswas, L., Kumar, V. A. & Biswas, R. Innate immune recognition of microbial cell wall components and microbial strategies to evade such recognitions. Microbiol. Res 168, 396-406 (2013).
69. Markova, N. et al. Cell wall-deficient forms (L-forms) of Listeria monocytogenes in experimentally infected rats. Zentralbl Bakteriol 286, 46-55 (1997).
70. Mihailova, L., Markova, N., Radoucheva, T., Veljanov, D. & Radoevska, S. Cell interactions of Listeria monocytogenes L. forms and peritoneal exudative cells in rats. Can J Microbiol 39, 1014-1021 (1993).
71. Michailova, L. et al. Atypical behavior and survival of Streptococcus pyogenes L forms during intraperitoneal infection in rats. FEMS Immunol Med Microbiol 28, 55-65 (2000).
72. Michailova, L., Kussovsky, V., Radoucheva, T., Jordanova, M. & Markova, N. Persistence of Staphylococcus aureus L-form during experimental lung infection in rats. FEMS Microbiol Lett 268, 88-97 (2007).
73. Allan, E., Hoischen, C. & Gumpert, J. Bacterial L-forms. Adv. Appl. Microbiol 68, 1-39 (2009).
74. Ratnam, S. & Chandrasekhar, S. The Pathogenicity of Spheroplasts of Mycobacterium tuberculosis. Am J Respir Diseases 114(1976).
75. Glover, W., Yang, Y. & Zhang, Y. Insights into the Molecular Basis of L-Form Formation and Survival in Escherichia coli. PLoS ONE 4, e7316 (2009).
76. Embden, J. V. et al. Strain identification of Mycobacterium tuberculosis by DNA fingerprinting: recommendations for a standardized methodology. J Clin Microbiol 31, 406-409 (1993).
77. Ortu, S. et al. Rapid detection and identification of Mycobacterium tuberculosis by Real Time PCR and Bactec 960 MIG. New Microbiol 29, 75-80 (2006).